Latest Revenue Streaming News

Sovereign Metals has unveiled a robust Definitive Feasibility Study for its Kasiya project, projecting a US$2.2 billion pre-tax NPV and positioning the mine as a critical non-Chinese supplier of rutile, graphite, and heavy rare earths to the US and allies.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

Fortuna Metals has declared a maiden mineral resource at its Mkanda project in Malawi, ranking it among the top six rutile deposits worldwide, while locking in a strategic US investment of A$8.6 million from WNDR to boost market exposure.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

Epiminder has leveraged its $125 million IPO to advance clinical enrolments, boost Medicare reimbursement, and develop its next-generation Minder device, positioning for a commercial launch in early 2028.

Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.

Advanced Braking Technology (ASX: ABV) posted a record $6.2 million in product sales for Q4 FY26, lifting full-year revenue 22.7% to $23.5 million. The company’s autonomous BRAKEiQ system advanced key milestones as international engagement expanded.

Streamplay Studio Limited has reported its fifth straight quarter of positive operating cash flow, driven by strong customer receipts and strategic publishing deals. The company is advancing multiple game releases and expanding its cloud gaming footprint across new regions.

OMG Group delivered a near 50% jump in FY26 net sales, expanding its product range nationally and breaking into international markets with new distribution agreements.

Emyria has expanded its Empax clinic network across four states, reporting a 210% revenue increase in FY26 and early clinical success in treatment-resistant depression.

Cue Energy Resources posted a solid quarter with a 16% production rise and $13.6 million cash receipts, backed by new drilling and a refreshed board after Horizon Oil's takeover.

InteliCare generated positive cash flow for the first time since listing in the June 2026 quarter, driven by accelerated deployments across aged care and retirement living sectors.